Plasmatech Biopharmaceuticals
NASDAQ: ABEODallas, US · Delaware corporation
Founders & leadership
JH
Jeffrey H. DavisExecutive
SB
Stephen B. ThompsonExecutive
Board
SH
Steven H. RouhandehBoard director
MA
mark AlvinoBoard director
TW
Todd WidderBoard director
MJ
Mark J. AhnBoard director
SB
Stephen B. HowellBoard director
Reported raises · per SEC filings
Form D private placements$23.7M disclosed across 2 rounds · 2015
▶$13.7MraisedJun 2015 · 17 investors · PharmaceuticalsRule 506(b)
▶$13.7MraisedJun 2015 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen B. HowellDirector
- Jeffrey H. DavisDirector
- Tim MillerExecutive Officer, Director
- Steven H. RouhandehExecutive Officer
- Stephen B. ThompsonExecutive Officer
- Todd WiderDirector
- Mark J. AhnDirector
- Mark AlvinoDirector
- Offering amount
- $22.7M
- Amount sold
- $13.7M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMay 2015 · 2 investors · PharmaceuticalsRule 506(c)
▶$10MraisedMay 2015 · 2 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey H. DavisDirector
- Steven H. RouhandehExecutive Officer
- mark AlvinoDirector
- Mark J. AhnDirector
- Stephen B. ThompsonExecutive Officer
- Todd WidderDirector
- Stephen B. HowellDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $1.1M
- Placement agents
- H. C. Wainwright & Co., LLC
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Plasmatech Biopharmaceuticals raised?
- Plasmatech Biopharmaceuticals has disclosed $23.7M raised across 2 rounds.
- Where is Plasmatech Biopharmaceuticals headquartered?
- Plasmatech Biopharmaceuticals is headquartered in Dallas, US.